BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30338520)

  • 1. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
    Nagalla S; Ballas SK
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003426. PubMed ID: 30338520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
    Nagalla S; Ballas SK
    Cochrane Database Syst Rev; 2016 Mar; 3():CD003426. PubMed ID: 26942338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
    Nagalla S; Ballas SK
    Cochrane Database Syst Rev; 2012 Jul; (7):CD003426. PubMed ID: 22786485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
    Nagalla S; Ballas SK
    Cochrane Database Syst Rev; 2010 Jan; (1):CD003426. PubMed ID: 20091545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
    Singh PC; Ballas SK
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003426. PubMed ID: 17943791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
    Riddington C; De Franceschi L
    Cochrane Database Syst Rev; 2002; (4):CD003426. PubMed ID: 12519597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).
    Ataga KI; Reid M; Ballas SK; Yasin Z; Bigelow C; James LS; Smith WR; Galacteros F; Kutlar A; Hull JH; Stocker JW;
    Br J Haematol; 2011 Apr; 153(1):92-104. PubMed ID: 21323872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium for treating sickle cell disease.
    Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011358. PubMed ID: 31498421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium for treating sickle cell disease.
    Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011358. PubMed ID: 28409830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Estcourt LJ; Kohli R; Hopewell S; Trivella M; Wang WC
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003146. PubMed ID: 32716555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Wang WC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD003146. PubMed ID: 28094851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piracetam for reducing the incidence of painful sickle cell disease crises.
    Al Hajeri A; Fedorowicz Z
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD006111. PubMed ID: 26869149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piracetam for reducing the incidence of painful sickle cell disease crises.
    Al Hajeri AA; Fedorowicz Z; Omran A; Tadmouri GO
    Cochrane Database Syst Rev; 2007 Apr; (2):CD006111. PubMed ID: 17443614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for chronic kidney disease in people with sickle cell disease.
    Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012389. PubMed ID: 28500860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc supplements for treating thalassaemia and sickle cell disease.
    Swe KM; Abas AB; Bhardwaj A; Barua A; Nair NS
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009415. PubMed ID: 23807756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytomedicines (medicines derived from plants) for sickle cell disease.
    Oniyangi O; Cohall DH
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD004448. PubMed ID: 32977351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled nitric oxide for treating pain crises in people with sickle cell disease.
    Aboursheid T; Albaroudi O; Alahdab F
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD011808. PubMed ID: 35802341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytomedicines (medicines derived from plants) for sickle cell disease.
    Oniyangi O; Cohall DH
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004448. PubMed ID: 29446825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.